marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Tarsus Pharmaceuticals Financial Ratios 2011-2024 | TARS
Annual Financial Ratios Tarsus Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-8.6 | -15.7 | -32.7 | - | - | - | - | - | - | - | - | - | - |
P/S |
66.9 | 37.9 | 7.9 | - | - | - | - | - | - | - | - | - | - |
EPS |
-4.6 | -2.5 | -0.7 | -4.3 | -2.0 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
1.01 B | 941 M | 293 M | 545 M | 6.35 M | 3.74 M | - | - | - | - | - | - | - |
EBITDA per Share |
-4.85 | -2.53 | -0.577 | -1.43 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-24.7 | -20.0 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | - | - | - | - | - | - | - | - | - | - | ||
P/B |
5.9 | 5.1 | 2.7 | 4.3 | - | - | - | - | - | - | - | - | - |
P/CF |
-9.9 | -19.9 | 120.6 | -32.8 | - | - | - | - | - | - | - | - | - |
ROE % |
-68.99 | -32.19 | -8.29 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-51.19 | -27.25 | -7.73 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-72.67 | -32.51 | -7.29 | -16.21 | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.9 | 6.5 | 14.7 | 31.7 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Tarsus Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.61 | -0.88 | -1.01 | - | -1.28 | -1.17 | -0.88 | - | -0.84 | -0.24 | -0.98 | - | -0.76 | 0.31 | -0.51 | - | -3.71 | -1.23 | -0.74 | - | -0.28 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.65 | -0.88 | -1.06 | - | -1.33 | -1.22 | -0.93 | - | -0.86 | -0.21 | -0.94 | - | -0.76 | 0.36 | 0.53 | - | -3.71 | -1.22 | -0.79 | - | -0.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-54.36 | -62.83 | -70.90 | -53.10 | -64.21 | -57.00 | -38.32 | -27.27 | -36.03 | -33.68 | -27.79 | 0.20 | -5.91 | -3.26 | -8.51 | -9.25 | 2.10 | 19.54 | 42.70 | 88.92 | 88.92 | 77.58 | 56.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-39.88 | -48.24 | -56.04 | -42.31 | -51.83 | -46.76 | -32.40 | -22.94 | -31.19 | -29.91 | -24.52 | 0.22 | -5.67 | -3.32 | -8.33 | -8.92 | -10.09 | -5.36 | -3.47 | -1.17 | -1.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-56.65 | -65.21 | -74.23 | -55.77 | -67.07 | -59.22 | -39.36 | -26.75 | -35.51 | -32.98 | -26.83 | 0.86 | -5.25 | -2.59 | -8.34 | -9.35 | 1.19 | 17.84 | 19.81 | 10.54 | 10.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.7 | 3.0 | 4.7 | 3.9 | 4.9 | 4.6 | 5.6 | 6.5 | 7.0 | 8.1 | 5.6 | 14.7 | 16.9 | 18.5 | 18.1 | 28.7 | 28.7 | 28.7 | 28.7 | 63.5 | 63.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
55.6 | 66.4 | 76.8 | - | - | - | 45.6 | - | - | 0.1 | 1.4 | - | 735.9 | 93.2 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | 709.8 | 9517.6 | - | 3729.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
55.6 | 66.4 | 76.8 | - | - | - | 45.6 | - | - | 0.1 | 1.4 | - | 735.9 | 93.2 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
55.6 | 66.4 | 76.8 | - | - | - | 45.6 | - | - | -709.7 | -9516.2 | - | -2993.4 | 93.2 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency